Evidence map›Paper›PMID 41462070›Full record

ArticleBMC bioinformatics2025

DriverSub-SVM: a machine learning approach for cancer subtype classification by integrating patient-specific and global driver genes.

Junrong Song, Yuanli Gong, Zhiming Song, Xinggui Xu, Kun Qian, Yingbo Liu

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junrong SongSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China. zz2144@ynufe.edu.cn.
Yuanli GongSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China.
Zhiming SongSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China. zz2145@ynufe.edu.cn.
Xinggui XuSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China.
Kun QianSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China.
Yingbo LiuSchool of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China. liuyb@ynufe.edu.cn.

Funding

National Natural Science Foundation of China 62161051National Natural Science Foundation of China 62202415National Natural Science Foundation of China 62362064Talent Introduction Project of Yunnan University of Finance and Economics 2024D44the Graduate Innovation Fund Project Yunnan University of Finance and Economics 2025YUFEYC101Yunnan Fundamental Research Projects 202201AU070115Yunnan Fundamental Research Projects 202201AU070116
6 · The paper itself

Abstract

backgroundCancer's complexity and heterogeneity pose significant challenges for personalized treatment. Accurate classification of patients into molecular subtypes is critical for targeted therapy and improved outcomes. However, existing methods often fail to simultaneously capture inter-patient heterogeneity and shared molecular patterns in driver gene profiles.

resultsTo address this limitation, we propose DriverSub-SVM, a novel framework for interpretable cancer subtype classification that integrates patient-specific and cohort-wide driver gene information. Our method first models the bidirectional influence between mutated and dysregulated genes via a random walk on a functional interaction network. It then applies Bayesian Personalized Ranking (BPR) to infer personalized driver gene rankings for each patient. These rankings are aggregated into a consensus driver gene set using the Condorcet. Subsequently, a One-Against-One Multiclass Support Vector Machine (OAO-MSVM) classifies patients based on their gene-level profiles. Evaluated on multiple TCGA datasets, DriverSub-SVM outperformed four state-of-the-art methods, achieving higher accuracy and identifying clinically relevant genes associated with prognosis and therapeutic response.

conclusionDriverSub-SVM offers an effective and interpretable approach for cancer subtype classification by bridging individual heterogeneity and population-level patterns. It enhances understanding of tumor biology and holds promise for precision oncology and biomarker discovery. The source code is available at https://github.com/sjunrong/DriverSub-SVM .

Indexed as

Machine LearningNeoplasmsSupport Vector MachineAlgorithmsBayes TheoremHumansCancer subtype classificationConcensus gene selectionDriver gene identificationInterpretable machine learningMulticlass SVMPersonalized ranking

Identifiers

PMID41462070
PMCPMC12751776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.